acute myelogenous leukemia
Showing NaN - NaN of 29
Acute Myelogenous Leukemia, AML Trial in Worldwide (Venetoclax, Cytarabine)
Completed
- Acute Myelogenous Leukemia
- AML
-
Kansas City, Kansas
- +8 more
Aug 3, 2022
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,
Recruiting
- Acute Lymphoblastic Leukemia
- +7 more
- Busulfan
- +11 more
-
Duarte, California
- +26 more
Aug 11, 2022
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Lymphoma Trial in United States (biological, drug, procedure)
Active, not recruiting
- Acute Lymphoblastic Leukemia
- +3 more
- BPX-501 dose 1
- +5 more
-
Atlanta, Georgia
- +7 more
Jul 10, 2022
Acute Myelogenous Leukemia Trial in Australia, Canada, United States (Decitabine, Vorinostat, Filgrastim (G-CSF))
Completed
- Acute Myelogenous Leukemia
- Decitabine
- +4 more
-
Los Angeles, California
- +32 more
Jun 22, 2022
Acute Myeloid Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Worldwide (FT-2102 (olutasidenib),
Active, not recruiting
- Acute Myeloid Leukemia
- +2 more
- FT-2102 (olutasidenib)
- +2 more
-
Los Angeles, California
- +59 more
Mar 2, 2022
Acute Myeloid Leukemia, Leukemia, Acute Myeloid, Myeloid Leukemia, Acute Trial in Canada, United States (Iomab-B, Conventional
Active, not recruiting
- Acute Myeloid Leukemia
- +8 more
- Iomab-B
- +2 more
-
Gilbert, Arizona
- +23 more
Feb 22, 2022
Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma Trial in United States (Haploidentical Bone Marrow
Completed
- Acute Lymphocytic Leukemia
- +6 more
- Haploidentical Bone Marrow Transplant
- Double Umbilical Cord Blood Transplant
-
Birmingham, Alabama
- +38 more
Nov 2, 2021
Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Juvenile Myelomonocytic Leukemia Trial in New York (Fludarabine, Busulfan,
Completed
- Acute Myelogenous Leukemia
- +2 more
- Fludarabine
- +5 more
-
New York, New YorkColumbia University Medical Center
Aug 4, 2021
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in New York (radiation, drug,
Completed
- Acute Lymphoblastic Leukemia
- +3 more
- total body irradiation
- +7 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
May 17, 2021
Acute Myelogenous Leukemia, Acute Myeloid Leukemia Trial in Worldwide (MCLA-117 bispecific antibody)
Active, not recruiting
- Acute Myelogenous Leukemia
- Acute Myeloid Leukemia
- MCLA-117 bispecific antibody
-
Augusta, Georgia
- +9 more
May 6, 2021
Acute Myelogenous Leukemia Trial in United States (KIR genotype)
Completed
- Acute Myelogenous Leukemia
- KIR genotype
-
Scottsdale, Arizona
- +18 more
Mar 9, 2021
Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Trial in United States (Infusion of one MPC
Completed
- Acute Myelogenous Leukemia
- +3 more
- Infusion of one MPC expanded cord unit and one unexpanded cord unit
- Infusion of two unexpanded cord blood units.
-
Miami, Florida
- +8 more
Jun 25, 2020
Acute Myeloid Leukemia, Acute Myelogenous Leukemia Trial in Canada, United States (Azacitidine, Lenalidomide, Best Supportive
Completed
- Acute Myeloid Leukemia
- Acute Myelogenous Leukemia
- Azacitidine
- +2 more
-
Tucson, Arizona
- +29 more
Jun 17, 2019
Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Acute Lymphocytic Leukemia Trial in New York (device, drug, procedure)
Terminated
- Acute Myelogenous Leukemia
- +4 more
- CliniMACS® CD34 Reagent System
- +5 more
-
New York, New YorkWeill Cornell Medical College
Jun 12, 2018
Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in New York (micafungin, posaconazole)
Completed
- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Apr 4, 2018
Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in New York (CPX-351)
Completed
- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome
-
New York, New YorkWeill Cornell Medical College
Jan 12, 2018
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Non-Hodgkins Lymphoma Trial in United States (Food Safety Guidelines,
Completed
- Acute Lymphoblastic Leukemia
- +4 more
- Food Safety Guidelines
- Neutropenic Diet
-
San Diego, California
- +5 more
Feb 7, 2017
Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, MDS Trial in United States (KW-2449)
Terminated
- Acute Myelogenous Leukemia
- +3 more
-
Baltimore, Maryland
- +3 more
Aug 16, 2016
Myelodysplastic Syndrome, Acute Myelogenous Leukemia Trial in United States (MGCD0103)
Completed
- Myelodysplastic Syndrome
- Acute Myelogenous Leukemia
-
Los Angeles, California
- +7 more
Jun 4, 2015
Acute Myelogenous Leukemia, Acute Myeloid Leukemia Trial in United States (clofarabine)
Completed
- Acute Myelogenous Leukemia
- Acute Myeloid Leukemia
-
Phoenix, Arizona
- +19 more
Mar 17, 2014
Acute Myelogenous Leukemia Trial in Worldwide (clofarabine (IV formulation), , cytarabine)
Completed
- Acute Myelogenous Leukemia
- clofarabine (IV formulation)
- +2 more
-
Scottsdale, Arizona
- +56 more
Mar 17, 2014
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Relapsed Leukemia Trial in United States (clofarabine, Etoposide,
Completed
- Acute Lymphoblastic Leukemia
- +2 more
- clofarabine
- +2 more
-
Birmingham, Alabama
- +12 more
Mar 17, 2014